Navigation Links
Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Date:8/5/2011

of which are proprietary, such as ADD-Vantage drug delivery system and iSecure prefilled syringes. Therapeutic segments include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, emergency and other areas. Hospira also has robust pipelines of both generic and biosimilar drugs.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the growth opportunities for generic specialty injectable products. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, regulatory, legal, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hospira Reports Second-Quarter 2011 Results
2. Hospira to Host Conference Call for Second-Quarter 2011 Results
3. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
4. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
5. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
6. Hospira Reports First-Quarter 2011 Results
7. Hospira Board Authorizes $1 Billion Share Repurchase Program
8. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
9. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
10. Hospira to Host Conference Call for First-Quarter 2011 Results
11. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  The packaging industry plays ... not only provides containment and drug safety but ... delivery. As patent loss delivers more generics into ... rise, in turn encouraging low-cost innovation in emerging ... to drive the pharmaceutical packaging industry towards low-cost, ...
(Date:3/3/2015)... DUBLIN , March 3, 2015 Actavis ... it has priced an offering of $21 billion aggregate ... in a registered public offering to be issued by ... by certain of its other subsidiaries (the "Notes"), as ... to PublicFloating Rate Senior Notes* , $500,000,000 ...
(Date:3/3/2015)... AUSTIN, Texas , March 3, 2015  Vermillion, Inc. ... on gynecologic disease, today announced management will present at the ... at the Ritz-Carlton in Dana Point, California ... President and CEO of Vermillion, Valerie Palmieri , will ... She will be joined by Eric Schoen , the ...
Breaking Medicine Technology:Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Tongjitang Chinese Medicines Company (the "Company" ... specialty pharmaceutical company focusing on the development, manufacturing, marketing ... today announced its financial results for the quarter and ... Financial Results for the Quarter ...
... Md., March 25, 2011 The U.S. Food and Drug ... late-stage (metastatic) melanoma, the most dangerous type of skin ... Melanoma is the leading cause of death ... melanoma were diagnosed in the United States during 2010 ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 2Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 3Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 4Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 5Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 6Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 7Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 8Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 9Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 10Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 11Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 12Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 13Tongjitang Chinese Medicines Company Reports Fourth Quarter and Full Year 2010 Financial Results 14FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 2FDA Approves New Treatment for a Type of Late-Stage Skin Cancer 3
(Date:3/3/2015)... (PRWEB) March 04, 2015 As payers ... value-based payment contracts within the next few years, they ... the significant chunk of health care spending they control ... Inc.’s ACO Business News (ABN) tracks some of ... of a commercial accountable care organization (ACO)-type model. , ...
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, ... States District Court for the Northern District of Ohio ... as insurance companies Balboa, QBE, and Newport Management. (See ... 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, says ... her to buy too much insurance at rates that ...
(Date:3/3/2015)... March 03, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... NOVAtime SaaS Workforce Management / Time and ... attendance processes. , Since 2004, Innovative Services’ ... disabilities with the best quality of life. The ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Risperdal ... to market the atypical antipsychotic medication continue to ... to court documents, the South Carolina Supreme Court ... Johnson & Johnson’s Janssen Pharmaceuticals unit had deceptively ... However, while the Court’s February 25th decision characterized ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... New research shows bone marrow stem cells may help ... reporting at the American Heart //Association’s Scientific Sessions 2003 ... breakthrough trial that took place in 2001. Results from ... made from his own bone marrow had improved heart ...
... predict a person's risk of developing heart disease in ... finds childhood levels of low-density lipoprotein, or LDL, and ... wall thickness in young adults. The carotid artery is ... transports blood from the heart to the brain. Thickening ...
... are obese are more likely to have behavior problems ... University of Michigan studied more than 750 children between ... took part in the National Longitudinal Survey //of Youth ... health, education, demographic, and socioeconomic status. Children were classified ...
... in nearly half of the cases, Some pre-term births are ... //bleeding or stretching of the uterus. But in the rest, ... explain part of the problem. ,Premature birth -- when ... is a major public health concern because underdeveloped babies are ...
... the virus that killed 774 people remains unknown. Scientists believe people ... another source.// ,"You might want to quarantine the pets ... on emerging diseases at the University of Texas Medical Branch in ... cat to cat, it doesn't take much of a leap of ...
... creating a whole new experience for patients in dentist ... more smiles on their patients' faces.// ,Laser procedures ... removal, less bleeding and less discomfort for patients. There ... diagnose cavities, while others remove gum and tooth structure ...
Cached Medicine News:Health News:Elevated LDL levels in Childhood could be Predictors of Heart Disease 2Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2Health News:Some pets found to be SARS carriers 2
Scoville-Greenwood bayonet forceps...
Angled 60 degree blades 5.5 mm....
... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
Medicine Products: